Multiple Myeloma

Here are five ways to live your best life while undergoing CAR T-cell therapy.

While CAR T therapy is becoming more accessible, many question the data supporting its use. Here's what you should know about it in pretreated myeloma.

People experiencing a relapse of multiple myeloma have unique needs. An oncology social worker who focuses on people with this condition offers tips to help.

Care partners may want to familiarize themselves with the following ten key facts before their loved one undergoes this treatment.

Blood cancer specialists share their insights on potential CAR T-cell therapy risks and what you can do to prepare.

If you have multiple myeloma that isn’t responding to treatment, you have options. Read on to learn more about the condition and what can be done about it.

Discover nine facts about CAR-T cell therapy, how it works, and the mechanism it uses to help treat multiple myeloma.

Check out this breakdown of what to expect, including several pre-treatment appointments, the actual CAR T infusion, and follow-up appointments.

In this series, learn about how CAR T-cell therapy can treat multiple myeloma, the logistics involved, and whether it’s right for you.

CAR T-cell therapy reprograms T-cells to target myeloma, while stem cell transplants replace damaged marrow after high-dose chemotherapy.

CAR T-cell therapy for multiple myeloma modifies T-cells to target BCMA on myeloma cells, offering precision and durable remission.

Daratumumab reduced the risk for progression or death compared with active monitoring among patients with high-risk smoldering multiple myeloma, new data show.